ALX Oncology Holdings Inc.

ALXO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$17,567$22,406$48,822$363,667
Short-Term Investments$110,190$160,330$217,385$0
Receivables$892$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,703$5,923$4,762$3,352
Total Curr. Assets$134,352$188,659$270,969$367,019
Property Plant & Equip (Net)$9,632$10,841$9,813$3,472
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$3,524$35,411$16,699$0
Tax Assets$0$0$0$0
Other NC Assets$267$7,642$9,008$9,692
Total NC Assets$13,423$53,894$35,520$13,164
Other Assets$0$0$0$0
Total Assets$147,775$242,553$306,489$380,183
Liabilities
Payables$4,497$8,591$8,073$3,764
Short-Term Debt$2,347$1,575$1,041$742
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$11,656$25,835$19,211$10,789
Total Curr. Liab.$18,500$36,001$28,325$15,295
LT Debt$14,631$15,622$9,389$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,026$1,218$5,311$1,839
Total NC Liab.$15,657$16,840$14,700$1,839
Other Liabilities$0$0$0$0
Cap. Leases$7,074$7,558$1,041$742
Total Liabilities$34,157$52,841$43,025$17,134
Equity
Pref Stock$0$0$0$0
Common Stock$53$50$41$41
Retained Earnings-$621,122-$486,272-$325,467-$201,985
AOCI$275$256-$845$0
Other Equity$734,412$675,678$589,735$564,993
Total Equity$113,618$189,712$263,464$363,049
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$147,775$242,553$306,489$380,183
Net Debt-$589-$5,209-$38,392-$362,925
ALX Oncology Holdings Inc. (ALXO) Financial Statements & Key Stats | AlphaPilot